More pie in the sky - imo this deal with a very poor up front payment shows SC needs to go - lacks the skills required to get deals done which have the proper up front payment, far below what they showed in their table below - so this is why the sp is so low
From SUDA’s Corporate Presentation reissued in April 2018
COMPARABLE COLLABORATION/TRADE SALE DEALS
Generic drug Sumatriptan
Delivery Technology Nasal spray
Disease Migraine
Licensor/Licensee Optinose/Avanir
Territory North America
Upfront Payment US$20M
Milestones US$90M
Royalties on Sales Yes, tiered
Date Signed July 2013
Ann: SUDA Signs Agreement For SUD-001H For US Market, page-105
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $210.3M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $208.7K | 1.044M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 724168 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 221193 | 3 |
View Market Depth
| Last trade - 12.09pm 16/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |